LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

CorMedix Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCRMD
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CRMD COVERAGE

What’s moving CorMedix Inc. now

Current reporting with the operating signal separated from the noise.

01
Quiver Quantitative

Lobbying Update: $220,000 of CORMEDIX INC. lobbying was just disclosed

The story matters when it changes CorMedix Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
TradingKey

CorMedix Inc (CRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk

The story matters when it changes CorMedix Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
TradingKey

CorMedix Inc (CRMD) Financial Health: Profitability & Balance Sheet Analysis

Investors are testing whether CorMedix Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
TradingKey

CorMedix Inc (CRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

The story matters when it changes CorMedix Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
TradingView

CorMedix Inc. Revenue Breakdown – MUN:19KA

Investors are testing whether CorMedix Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
TradingKey

CRMD|CorMedix Inc|Price:7.195|Chg%:-0.155

The story matters when it changes CorMedix Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CRMD filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-05 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-02 · Period 2026-06-29SEC ↗8-KMaterial company eventFiled 2026-07-01 · Period 2026-06-25SEC ↗8-KMaterial company eventFiled 2026-06-24 · Period 2026-06-23SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-29 · Period 2026-06-23SEC ↗S-8 POSOfficial SEC filingFiled 2026-06-25SEC ↗
EARNINGS / QUARTERLY TRACKER

CorMedix Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.